Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

Market Cap	4.99B +4.1%
Revenue (ttm)	462.72M -21.6%
Net Income	120.87M +33.6%
EPS	0.95 +34.1%
Shares Out	127.08M
PE Ratio	41.20
Forward PE	n/a
Dividend	1.20 (3.06%)
Ex-Dividend Date	Jul 18, 2025

Volume	315,116
Average Volume	1,025,827
Open	39.40
Previous Close	39.36
Day's Range	39.20 - 39.58
52-Week Range	33.10 - 45.00
Beta	0.80
RSI	42.48
Earnings Date	Apr 30, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. Further, it offers infectious disease, fertility, fe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 720
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688075

Financial Performance

In 2024, Assure Tech (Hangzhou)'s revenue was 540.70 million, an increase of 7.42% compared to the previous year's 503.36 million. Earnings were 192.30 million, an increase of 35.85%.